1.Understand how value for money drives the commissioning of new cance drugs in a government-funded health care system.
2.Observe the degree of access to cancer drugs in England and emerging real world evidence of outcomes
3.Understand ways of maintaining access to cancer drugs at the same time as minismising the cost.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation